Search Results - "DUFFIELD, Emma"

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS) by FUKUOKA, Masahiro, WU, Yi-Long, DUFFIELD, Emma L, RUKAZENKOV, Yuri, SPEAKE, Georgina, HAIYI JIANG, ARMOUR, Alison A, TO, Ka-Fai, CHIH-HSIN YANG, James, MOK, Tony S. K, THONGPRASERT, Sumitra, SUNPAWERAVONG, Patrapim, LEONG, Swan-Swan, SRIURANPONG, Virote, CHAO, Tsu-Yi, NAKAGAWA, Kazuhiko, CHU, Da-Tong, SAIJO, Nagahiro

“…The results of the Iressa Pan-Asia Study (IPASS), which compared gefitinib and carboplatin/paclitaxel in previously untreated never-smokers and light…”
Get full text

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma by Mok, Tony S, Wu, Yi-Long, Thongprasert, Sumitra, Yang, Jin-Ji, Yang, Chih-Hsin, Chu, Da-Tong, Saijo, Nagahiro, Sunpaweravong, Patrapim, Han, Baohui, Margono, Benjamin, Ichinose, Yukito, Nishiwaki, Yutaka, Ohe, Yuichiro, Chewaskulyong, Busyamas, Jiang, Haiyi, Duffield, Emma L, Watkins, Claire L, Armour, Alison A, Fukuoka, Masahiro

“…This trial compared gefitinib, an inhibitor of the tyrosine kinase of epidermal growth factor (EGFR), with carboplatin plus paclitaxel as initial treatment of…”
Get full text

Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer by Goto, Koichi, Ichinose, Yukito, Ohe, Yuichiro, Yamamoto, Nobuyuki, Negoro, Shunichi, Nishio, Kazuto, Itoh, Yohji, Jiang, Haiyi, Duffield, Emma, McCormack, Rose, Saijo, Nagahiro, Mok, Tony, Fukuoka, Masahiro

“…In IPASS (IRESSA Pan-Asia Study), clinically selected patients with pulmonary adenocarcinoma received first-line gefitinib or carboplatin/paclitaxel. This…”
Get more information

Gefitinib Versus Vinorelbine in Chemotherapy-Naïve Elderly Patients With Advanced Non–Small-Cell Lung Cancer (INVITE): A Randomized, Phase II Study by CRINO, Lucio, CAPPUZZO, Federico, DUFFIELD, Emma L, ARMOUR, Alison A, SPEAKE, Georgina, CULLEN, Michael, ZATLOUKAL, Petr, RECK, Martin, PESEK, Milos, THOMPSON, Joyce C, FORD, Hugo E. R, HIRSCH, Fred R, VARELLA-GARCIA, Marileila, GHIORGHIU, Serban

“…This phase II, open-label, parallel-group study compared gefitinib with vinorelbine in chemotherapy-naïve elderly patients with advanced non-small-cell lung…”
Get full text

A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist by Genovese, Mark C, van der Heijde, Désirée M, Keystone, Edward C, Spindler, Alberto J, Benhamou, Claude, Kavanaugh, Arthur, Fudman, Edward, Lampl, Kathy, O'Brien, Chris, Duffield, Emma L, Poiley, Jeffrey, Weinblatt, Michael E

“…Our 24-week study (NCT01197755; OSKIRA-3) compared the efficacy and safety of fostamatinib versus placebo in patients taking background methotrexate treatment…”
Get full text

Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non–Small-Cell Lung Cancer and Poor Performance Status by GOSS, Glenwood, FERRY, David, ZARENDA, Marc, ARMOUR, Alison A, WIERZBICKI, Rafal, LAURIE, Scott A, THOMPSON, Joyce, BIESMA, Bonne, HIRSCH, Fred R, VARELLA-GARCIA, Marileila, DUFFIELD, Emma, ATAMAN, Ozlem U

“…To compare gefitinib with placebo in chemotherapy naïve patients with advanced non-small-cell lung cancer (NSCLC) and poor performance status. NSCLC patients…”
Get full text

Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study) by Ballantyne, Christie M., MD, Weiss, Robert, MD, Moccetti, Tiziano, MD, Vogt, Anja, MD, Eber, Bernd, MD, Sosef, Froukje, MD, Duffield, Emma, MSc

“…Patients at risk of coronary heart disease may not achieve recommended low-density lipoprotein (LDL) cholesterol goals on statin monotherapy. This study was…”
Get full text

The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers by Jones, Rob J., Boyce, Tamsin, Fennell, Michael, Jacobs, Vivien, Pinto, Francesco, Duffield, Emma, Clack, Glen, Green, Tim, Kelly, John, Robertson, John

“…Demonstration of pharmacodynamic activity of new, targeted cancer drugs in tumour tissue is potentially important in guiding early drug development. However,…”
Get full text

Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS) by Thongprasert, Sumitra, Duffield, Emma, Saijo, Nagahiro, Wu, Yi-Long, Yang, James Chih-Hsin, Chu, Da-Tong, Liao, Meilin, Chen, Yuh-Min, Kuo, Han-Pin, Negoro, Shunichi, Lam, Kwok Chi, Armour, Alison, Magill, Patrick, Fukuoka, Masahiro

“…Evaluation of health-related quality-of-life (HRQoL) and symptom improvement were preplanned secondary objectives for the overall population and posthoc…”
Get more information

Library Management Systems in Legal Libraries: Case Study: Heritage IV by Duffield, Emma

“…Legal libraries, by their very nature, have highly specialised requirements when it comes to library automation. A traditional library management system, which…”
Get full text

Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China by WU, Yi-Long, CHU, Da-Tong, HAN, Baohui, LIU, Xuyi, ZHANG, Li, ZHOU, Caicum, LIAO, Meilin, MOK, Tony, JIANG, Haiyi, DUFFIELD, Emma, FUKUOKA, Masahiro

“…Aim:  In the IRESSA Pan‐Asia Study (IPASS), 1217 patients in East Asia with pulmonary adenocarcinoma who were never‐smokers or ex/light‐smokers received…”
Get full text

Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study by Faergeman, Ole, Hill, Laurie, Windler, Eberhard, Wiklund, Olov, Asmar, Roland, Duffield, Emma, Sosef, Froukje

“…Patients at high risk of cardiovascular disease frequently fail to reach recommended low-density lipoprotein cholesterol (LDL-C) goals, partly because statin…”
Get more information

Library Management Systems in Legal Libraries by Duffield, Emma

“…Legal libraries, by their very nature, have highly specialised requirements when it comes to library automation. A traditional library management system, which…”
Get full text